Castration therapy of prostate cancer results in downregulation of HIF-1α levels

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 3, 2012, Pages 1243-1248

  Al Ubaidi, Firas L T ^a,c   Schultz, Niklas ^a   Egevad, Lars ^b   Granfors, Torvald ^c   Helleday, Thomas ^a,d  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c CENTRAL HOSPITAL   (Sweden)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

HIF 1 ; Hypoxia inducible factor; Prostate cancer

Indexed keywords

ANDROGEN DEPRIVATION; BACKGROUND LEVEL; CORE BIOPSY; DOWN-REGULATION; HYPOXIA-INDUCIBLE FACTOR; HYPOXIA-INDUCIBLE FACTOR 1; LOCAL TUMOR CONTROL; LOCALLY ADVANCED PROSTATE CANCER; MEAN INTENSITY; ORCHIDECTOMY; PROSTATE CANCERS; TUMOR CELLS; UNDERLYING MECHANISM;

BIOPSY; RADIOTHERAPY; TUMORS;

DISEASES;

HYPOXIA INDUCIBLE FACTOR 1ALPHA; LEUPRORELIN;

ADULT; ADVANCED CANCER; ARTICLE; CASTRATION; CELL HYPOXIA; CLINICAL ARTICLE; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; MALE; NEEDLE BIOPSY; ORCHIECTOMY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROTEIN EXPRESSION;

AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; BIOLOGICAL MARKERS; BIOPSY, NEEDLE; CELL HYPOXIA; DOWN-REGULATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LEUPROLIDE; MALE; MIDDLE AGED; ORCHIECTOMY; PROSTATE; PROSTATIC NEOPLASMS; RADIATION TOLERANCE;

EID: 84856392899     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.10.038     Document Type: Article

References (20)

1. J. Ferlay, D.M. Parkin, and E. Steliarova-Foucher Estimates of cancer incidence and mortality in Europe in 2008 Eur J Cancer 46 2010 765 781
2. M. Bolla, G. Van Tienhoven, and P. Warde External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study Lancet Oncol 11 2010 1066 1073
3. A.L. Harris Hypoxia - a key regulatory factor in tumour growth Nat Rev Cancer 2 2002 38 47
4. G.L. Wang, B.H. Jiang, and E.A. Rue Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension Proc Natl Acad Sci U S A 92 1995 5510 5514
5. K.S. Kimbro, and J.W. Simons Hypoxia-inducible factor-1 in human breast and prostate cancer Endocr Relat Cancer 13 2006 739 749
6. H. Zhong, A.M. De Marzo, and E. Laughner Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases Cancer Res 59 1999 5830 5835
7. Z. Du, C. Fujiyama, and Y. Chen Expression of hypoxia-inducible factor 1alpha in human normal, benign, and malignant prostate tissue Chin Med J (Engl) 116 2003 1936 1939
8. H. Zhong, G.L. Semenza, and J.W. Simons Up-regulation of hypoxia-inducible factor 1alpha is an early event in prostate carcinogenesis Cancer Detect Prev 28 2004 88 93
9. B. Moeller, and M.W. Dewhirst HIF-I and tumour radiosensitivity Br J Cancer 95 2006 1 5
10. B.J. Moeller, Y.T. Cao, and C.Y. Li Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules Cancer Cell 5 2004 429 441
11. R. Vergis, C.M. Corbishley, and A.R. Norman Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study Lancet Oncol 9 2008 342 351
12. Y. Dai, K. Bae, and D.W. Siemann Impact of hypoxia on the metastatic potential of human prostate cancer cells Int J Radiat Oncol Biol Phys 81 2011 521 528
13. D.G. Bostwick Grading prostate cancer Am J Clin Pathol 102 4 Suppl. 1 1994 S38 S56
14. K.L. Talks, H. Turley, and K.C. Gatter The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages Am J Pathol 157 2000 411 421
15. F. Ponten, K. Jirstrom, and M. Uhlen The Human Protein Atlas: a tool for pathology J Pathol 216 2008 387 393
16. D.T.T. Yapp, J. Woo, and A. Kartono Non-invasive evaluation of tumour hypoxia in the Shionogi tumour model for prostate cancer with F-18-EF5 and positron emission tomography BJU Int 99 2007 1154 1161
17. D.M. Janoff, C. Peterson, and S. Mongoue-Tchokote Clinical outcomes of androgen deprivation as the sole therapy for localized and locally advanced prostate cancer BJU Int 96 2005 503 507
18. J.L. Boddy, S.B. Fox, and C. Han The androgen receptor is significantly associated with vascular endothelial growth factor and hypoxia sensing via hypoxia-inducible factors HIF-1a, HIF-2a, and the prolyl hydroxylases in human prostate cancer Clin Cancer Res 11 2005 7658 7663
19. M. Milosevic, P. Chung, and C. Parker Androgen withdrawal in patients reduces prostate cancer hypoxia: implications for disease progression and radiation response Cancer Res 67 2007 6022 6025
20. R.G. Bristow, and R.P. Hill Hypoxia, DNA repair and genetic instability Nat Rev Cancer 8 2008 180 192